Insight report on PharmaPoint Prophylactic Human Papillomavirus Vaccines – Canada Drug Market Forecast to 2022


“The Report PharmaPoint: Prophylactic Human Papillomavirus Vaccines – Canada Drug Forecast and Market Analysis to 2022 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. –”

The first prophylactic vaccine for immunization against human papillomavirus (HPV) became available in 2006. The Gobal HPV Vaccines Market is now well established, yet vaccine coverage rates amongst the traditional target population of adolescent girls remain persistently low. Initially HPV vaccines were developed and marketed solely to protect against cervical cancer. In recent years the role of HPV in other cancers has been increasingly recognized which has facilitated a shift towards vaccinating a wider population, most significant has been the inclusion of males in routine vaccine recommendations in some countries. The current HPV vaccines market is dominated by one major player, Mercks Gardasil, with GlaxoSmithKlines (GSKs) HPV vaccine Cervarix providing the only competition. The introduction of Mercks nine-valent vaccine (V503) is set to change the future landscape of the HPV vaccines sector.

The anticipated addition of boys to routine HPV vaccine recommendations by different Canadian provinces is expected to serve as a significant driver to growth within the HPV vaccines market in Canada over the forecast period. In addition, from primary research insight, GlobalData projects Mercks nine-valent vaccine V503 to be widely adopted in the country. This will also significantly enhance the size of the HPV vaccines sector in Canada.

Download Sample copy of this Report at :


– Overview of Prophylactic Human Papillomavirus Vaccines including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.

– Detailed information on the key drugs in the Canada including product description, safety and efficacy profiles as well as a SWOT analysis.

– Sales forecast for the top drugs in the Canada from 2012-2022.

– Analysis of the impact of key events as well the drivers and restraints affecting the Canada Prophylactic Human Papillomavirus Vaccines disease market.

Reasons to buy

– Understand and capitalize by identifying products that are most likely to ensure a robust return

– Stay ahead of the competition by understanding the changing competitive landscape for Prophylactic Human Papillomavirus Vaccines

– Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential

– Make more informed business decisions from insightful and in-depth analysis of drug performance

– Obtain sales forecast for drugs from 2012-2022 in the Canada

Follow us on LinkedIn:

Table of Contents

1 Table of Contents 4

1.1 List of Tables 7

1.2 List of Figures 8

2 Introduction 9

2.1 Catalyst 9

2.2 Related Reports 10

2.3 Upcoming Related Reports 11

3 Disease Overview 12

3.1 Etiology and Pathophysiology 12

3.1.1 Etiology 12

3.1.2 Pathophysiology 13

3.2 Symptoms 15

4 Vaccination Recommendations and Coverage Rates 17

4.1 Canada 17

4.1.1 Vaccination Recommendations and Policies 17

4.1.2 Vaccination Coverage 18

4.1.3 Clinical Practice 20

5 Competitive Assessment 22

5.1 Overview 22

5.2 Strategic Competitor Assessment 22

5.3 Product Profiles 24

5.3.1 Gardasil 24

5.3.2 Cervarix 30

6 Unmet Need and Opportunity 35

6.1 Overview 35

6.2 Protection against Multiple HPV Types 36

6.2.1 Unmet Need 36

6.2.2 Gap Analysis 37

6.2.3 Opportunity 38

6.3 Vaccine Coverage Rates 38

6.3.1 Unmet Need 38

6.3.2 Gap Analysis 39

6.3.3 Opportunity 39

6.4 Perception of Vaccine Safety 40

6.4.1 Unmet Need 40

6.4.2 Gap Analysis 41

6.4.3 Opportunity 41

6.5 Awareness of HPV Vaccination 42

6.5.1 Unmet Need 42

6.5.2 Gap Analysis 42

6.5.3 Opportunity 43

6.6 Affordability of HPV Vaccines 43

6.6.1 Unmet Need 43

6.6.2 Gap Analysis 44

6.6.3 Opportunity 44

6.7 Coverage of HPV Types Prevalent in Certain Populations 45

6.7.1 Unmet Need 45

6.7.2 Gap Analysis 46

6.7.3 Opportunity 46

6.8 Vaccine Compliance Rates 46

6.8.1 Unmet Need 46

About us is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.


Mr. Nachiket

State Tower

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-621-2074